Cervical cancer screening is a vital preventive measure that significantly reduces mortality through early detection of pre-cancerous lesions. Physicians should be familiar with current guidelines recommending HPV testing alone or in combination with Pap smear (co-testing) for women aged 30–65, and Pap smear alone starting from age 21. High-risk human papillomavirus (HPV) types are the primary cause of cervical cancer, making HPV testing a crucial tool. Timely screening, follow-up of abnormal results, and patient counseling on HPV vaccination are essential components of comprehensive care. Physicians must also be aware of screening modifications for immunocompromised individuals or those with prior cervical pathology.
Senior Consultant Gynecology Cancer Surgeon, Global Hospitals, Ahmedabad
Dr. Anjana Chauhan is a distinguished Gynecologic Cancer Surgeon with over a decade of expertise in diagnosing, managing, and surgically treating gynecological malignancies. Based in Ahmedabad, she has been at the forefront of women’s cancer care, spearheading multiple pioneering initiatives including India’s first HPV Clinic, dedicated to cervical cancer prevention and awareness. She specializes in the comprehensive management of gynecological cancers such as cervical, ovarian, uterine, and vulvar cancers — performing radical surgeries including Wertheim’s hysterectomy, staging laparotomies, debulking procedures, and extended hysterectomies. Her holistic approach also emphasizes conservative cancer treatment in young women and adolescents with a strong focus on fertility preservation, HPV vaccination advocacy, and quality of life post-treatment. A former Professor & Head of Department, she has mentored countless medical professionals and continues to deliver high-impact care at Radiance Hospitals and Global Hospital, Ahmedabad.